Name of ResourceOxford Parkinson Disease Centre (University of Oxford)
Name of Principal Investigator - Title
Name of Principal Investigator - First name
Name of Principal Investigator - Last name
Address of institution -Institution
Address of institution - Street address
Address of institution - City
Address of institution - Postcode
SummaryBAC trangsenic mouse and rat lines carrying wild-type or mutant variants of SNCA and LRRK2; human iPSC lines carrying mutations in SNCA, LRRK2, GBA and sporadic PD, plus controls
Q1a. Please indicate below if your cohort includes or expects to include, incidence of the following conditions? (1)Parkinson's disease & PD-related disorders
Q1b. Does your resource holdAnimals| Induced Pluripotent Stem Cells (iPSC)
Q2a. Does the resource act as a centre for access and distribution to external groups (who are not the Principal Investigators (PI) for the resource)?
Q2b. If Yes, what procedures and rules apply for access?Apply to PI or co-ordinator at resource|Access through collaboration with PI only| Access independent of collaboration with PI| Local/ regional access| National access| International access| Charge for retrieval
Q3a. Does your resource develop experimental models (animal/cell) for external groups?
Q3b. If YES and your resource is related to an ANIMAL model, what types of models are provided?
Q3c. If YES and your resource is related to a CELL model, what types of models are provided?
Q4a. Is this activity supported as:
Q4b. Do you deposit what you supply in any kind of central repository?
Available to external userYes through JAX| Yes Through Jax| Yes through www.rrc.us/
Full phenotypic characterPublished PMID24082145| Published PMID 24121116| Published PMID 26744332
Please indicate the phenotypesPublished| Published| Published
List of genotypes or other subtypesSNCA-OVX| SNCA-A30P| LRRK2-WT, LRRK2-G2019S, LRRK2-R1441C
Q5b. Cognitive function, No of models
Q5b. Cognitive function, Available to external users
Q5b. Cognitive function, Full phenotypic characterisation
Q5b. Cognitive function, Nature of phenotype
Q5b. Motor function, No of models
Q5b. Motor function, Available to external users
Q5b. Motor function, Full phenotypic characterisation
Q5b. Motor function, Nature of phenotype
Q5b. Physiological function, no of models
Q5b. Physiological function, Available to external users
Q5b. Physiological function, Full phenotypic characterisation
Q5b. Physiological function, Nature of phenotype
Q5b. Other function (please specify), no of models
Please specify other function
Q5b. Other function (please specify), Available to external users
Q5b. Other function (please specify), Full phenotypic characterisation
Q5b. Other function (please specify), Nature of phenotype
Q6. Please indicate if your resource is already linked into European or international consortia or networks?
Q7a. Is maintenance of this resource dependent on continued funding?
Q7b. If yes, when does the current funding period end?
Q7c. What is the expected lifespan of the resource (in years)?
Q7d. Are there other plans affecting future use that it may be useful to know?
Types: Experimental Models
Member States: United Kingdom
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A
Export as PDF